Rochester, NY 6/8/2009 11:04:13 PM
Late Morning Risers - Park Bancorp, Inc.,PFED - MFRI, Inc.,MFRI - XOMA Ltd.,XOMA - Sourced WhisperfromWallStreet.com
Park Bancorp, Inc. - MFRI, Inc. - XOMA Ltd.
Late Morning Risers - Park Bancorp, Inc.,PFED - MFRI, Inc.,MFRI - XOMA Ltd.,XOMA - Sourced WhisperfromWallStreet.com
Park Bancorp, Inc.,PFED
Park Bancorp, Inc. operates as the holding company for Park Federal Savings Bank that provides retail banking products and services in Illinois. It primarily engages in generating deposits and originating loans. The company's deposit products include passbook savings, NOW accounts, money market accounts, and certificates of deposit. Its lending portfolio comprises residential real estate loans comprising one-to-four- family and multi-family residential loans; construction and land, and commercial real estate loans; and consumer and other loans, such as automobile loans, second mortgage loans, loans secured by deposits, and commercial lines of credit secured by real estate. The company, through its other subsidiaries, engages in residential real estate development; and insurance activities. As of December 31, 2007, it operated three branches located in Chicago and Westmont, Illinois. The company was founded in 1921 and is based in Chicago, Illinois.
Last Trade: 10.18
Day's Range: 7.23 - 10.49
52wk Range: 2.85 - 20.40
Volume: 18,012
---
If you are viewing this press release you are obviously interested in making money in the stock market. In today’s market investors need every tool available. WhisperfromWallStreet.com sends FREE alerts to our subscribers on stocks that we feel are ready to move within hours or days. So far in 2009 we have sent 36 stock alerts to our clients and the average price gain has been 88%. To add additional profits to your portfolio please take a minute and sign up for our free alerts. There is no risk to you and you will see just how accurate we are in our alerts.
Investors sign up for our FREE alerts at http://whisperfromwallstreet.com
---
MFRI, Inc.,MFRI
MFRI, Inc. engages in the manufacture and sale of piping systems, filtration products, and industrial process cooling equipment in the United States and internationally. The company's Piping System segment engineers, designs, manufactures, and sells specialty piping systems, and leak detection and location systems. This segment?s specialty piping systems include industrial and secondary containment piping systems for transporting chemicals, waste streams, and petroleum liquids; insulated and jacketed district heating and cooling piping systems for energy distribution to various locations from central energy plants; and oil and gas gathering flow and long lines for oil and mineral transportation. Its leak detection and location systems are used to monitor areas, where fluid intrusion might contaminate the environment and endanger personal safety. Its Filtration Products segment manufactures and sells filter elements for air filtration and particulate collection systems. It markets air filtration-related products and accessories; and provides maintenance services consisting of dust collector inspection, filter cleaning, and filter replacement.
Last Trade: 7.89
Day's Range: 7.31 - 8.95
52wk Range: 4.05 - 18.00
Volume: 148,073
---
XOMA Ltd.,XOMA
XOMA Ltd., a biopharmaceutical company, engages in the discovery, development, and manufacture of therapeutic antibodies and other agents to treat inflammatory, autoimmune, infectious, and oncological diseases. The company receives royalties on three approved products: RAPTIVA, which is marketed globally for the treatment of chronic moderate-to-severe plaque psoriasis; LUCENTIS, which is marketed globally for the treatment of neovascular (wet) age-related macular degeneration; and CIMZIA, which is approved in the U.S. and Switzerland for the treatment of Crohn?s disease. Its products under development include XOMA 052, a monoclonal antibody for the treatment of Type 2 diabetes, rheumatoid arthritis, systemic juvenile idiopathic arthritis, and gout, which is in Phase 1 clinical studies; and XOMA 3AB, a biodefense anti-botulism antibody for the treatment of botulism poisoning.
Last Trade: 1.27
Day's Range: 1.10 - 1.34
52wk Range: 0.37 - 2.40
Volume: 15,797,191
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
WhisperfromWallStreet.com (WFWS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by WFWS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WFWS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.whisperfromwallstreet.com or mentioned herein. WFWS may have been compensated with shares or with cash from third party shareholders or the company on behalf of one or more of the companies mentioned in this opinion.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WFWS undertakes no obligation to update such statements.
This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
CONTACT: WhisperFromWallStreet.com
